Eliem Therapeutics Announces $60 Million Series B Financing May 24, 2021 07:00AM
Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders Mar 25, 2021 05:00AM